CTLT Catalent Inc

Price (delayed)

$108.37

Market cap

$18.45B

P/E Ratio

58.26

Dividend/share

N/A

EPS

$1.86

Enterprise value

$20.67B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It ...

Highlights

The net income has soared by 133% YoY and by 14% from the previous quarter
The company's EPS has surged by 116% YoY and by 14% QoQ
Catalent's quick ratio has increased by 19% YoY but it has decreased by 16% from the previous quarter
The stock's price to earnings (P/E) is 14% more than its 5-year quarterly average of 51.0 but 4.5% less than its last 4 quarters average of 61.0
The debt has grown by 5% YoY

Key stats

What are the main financial stats of CTLT
Market
Shares outstanding
170.23M
Market cap
$18.45B
Enterprise value
$20.67B
Valuations
Price to earnings (P/E)
58.26
Price to book (P/B)
5.17
Price to sales (P/S)
5.15
EV/EBIT
42.08
EV/EBITDA
27.11
EV/Sales
5.97
Earnings
Revenue
$3.46B
EBIT
$491.2M
EBITDA
$762.5M
Free cash flow
-$134.1M
Per share
EPS
$1.86
Free cash flow per share
-$0.81
Book value per share
$20.98
Revenue per share
$21.04
TBVPS
$29.64
Balance sheet
Total assets
$8.2B
Total liabilities
$4.38B
Debt
$3.06B
Equity
$3.46B
Working capital
$1.49B
Liquidity
Debt to equity
0.88
Current ratio
2.46
Quick ratio
1.57
Net debt/EBITDA
2.92
Margins
EBITDA margin
22%
Gross margin
32.3%
Net margin
10%
Operating margin
13.8%
Efficiency
Return on assets
3.8%
Return on equity
10%
Return on invested capital
8.6%
Return on capital employed
6.8%
Return on sales
14.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CTLT stock price

How has the Catalent stock price performed over time
Intraday
-4.75%
1 week
-5.89%
1 month
-4.8%
1 year
106.54%
YTD
4.13%
QTD
4.13%

Financial performance

How have Catalent's revenue and profit performed over time
Revenue
$3.46B
Gross profit
$1.12B
Operating income
$479.1M
Net income
$345.9M
Gross margin
32.3%
Net margin
10%
The net income has soared by 133% YoY and by 14% from the previous quarter
The net margin has soared by 85% YoY and by 8% from the previous quarter
Catalent's operating income has surged by 60% YoY and by 9% QoQ
Catalent's gross profit has increased by 30% YoY and by 6% from the previous quarter

Growth

What is Catalent's growth rate over time

Valuation

What is Catalent stock price valuation
P/E
58.26
P/B
5.17
P/S
5.15
EV/EBIT
42.08
EV/EBITDA
27.11
EV/Sales
5.97
The company's EPS has surged by 116% YoY and by 14% QoQ
The stock's price to earnings (P/E) is 14% more than its 5-year quarterly average of 51.0 but 4.5% less than its last 4 quarters average of 61.0
CTLT's equity has soared by 101% year-on-year and by 12% since the previous quarter
The price to book (P/B) is 23% higher than the last 4 quarters average of 4.2 and 10% higher than the 5-year quarterly average of 4.7
CTLT's price to sales (P/S) is 98% higher than its 5-year quarterly average of 2.6 and 32% higher than its last 4 quarters average of 3.9
The revenue has increased by 27% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Catalent business performance
The company's return on assets has surged by 73% YoY and by 12% QoQ
CTLT's return on invested capital is up by 37% year-on-year and by 4.9% since the previous quarter
Catalent's return on equity has increased by 35% YoY
The company's return on sales rose by 28% YoY and by 3.6% QoQ

Dividends

What is CTLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CTLT.

Financial health

How did Catalent financials performed over time
Catalent's total assets is 87% more than its total liabilities
Catalent's total assets has increased by 32% YoY and by 2.7% from the previous quarter
The current ratio is up by 24% year-on-year but it has declined by 3.9% since the previous quarter
The debt is 12% less than the equity
CTLT's equity has soared by 101% year-on-year and by 12% since the previous quarter
The company's debt to equity fell by 48% YoY and by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.